Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00574717 · ClinicalTrials.gov registry record · Phase 1
Enhancement of Emmetropization in Hyperopic Infants
A Phase 1 study, sponsored by Ohio State University.
- Terminated
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT00574717 is a Phase 1 study that was terminated before completion, run by Ohio State University. The registered enrollment target is 6 participants.
The verdict
NCT00574717, a Phase 1 study, was terminated before completion, sponsored by Ohio State University.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
To determine if wearing a moderate spectacle under-correction (3.00D) and performing activities designed to stimulate accurate accommodation during a 15-month period will enhance emmetropization in highly hyperopic (between +5.00D and +7.00D) 3-month old infants.
Interventions
- PROCEDURE Spectacles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2007-12 |
| Est. Completion | 2010-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00574717
The ClinicalTrials.gov registry entry for NCT00574717 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Spectacles is the first listed.
NCT00574717 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00574717 about?
NCT00574717 is a clinical study titled "Enhancement of Emmetropization in Hyperopic Infants". To determine if wearing a moderate spectacle under-correction (3.00D) and performing activities designed to stimulate accurate accommodation during a 15-month period will enhance emmetropization in highly hyperopic (between +5.00D and +7.00D) 3-month old infants.
What is the current status of trial NCT00574717?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2007-12. Estimated completion is 2010-09.
What interventions are being tested in trial NCT00574717?
The interventions under investigation include: Spectacles (PROCEDURE).
Who is sponsoring clinical trial NCT00574717?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.